Nitron Cryoconsole News Today

Medtronic plc (NYSE:MDT) Q3 2024 Earnings Call Transcript February 20, 2024 Medtronic plc beats earnings expectations. Reported EPS is $1.3, expectations were $1.26. Medtronic plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Ryan Weispfenning: [Video Presentation] Good morning and welcome […]

Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business...

MDT earnings call for the period ending December 31, 2023.

MDT earnings call for the period ending December 31, 2023.

/CNW/ -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024. Key...

Medtronic received the mark for its single-shot PFA device, clearing the company to expand its portfolio of European atrial fibrillation devices.

The company scored CE marks for its pulsed field ablation and cryoablation console devices to treat atrial fibrillation.

Recent developments of interest in cardiovascular medicine

The news of the nod for PulseSelect comes about eight months after Medtronic received a CE mark for its Affera mapping and ablation system.